A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

NCT00542009 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

252

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Management
Treatment Of Obesity

Interventions

DRUG: CE-326,597 100 mg QD
DRUG: CE-326,597 50 mg QD
DRUG: CE-326,597 25 mg QD
DRUG: Placebo
DRUG: CE-326,597 5mg QD

Sponsor

Pfizer